داروپخش

وپخش | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: - 0.00

Close Price: -

	2026/08/22 Fiscal Year 2026/03/2012 Month	2026/08/03 Fiscal Year 2026/03/2012 Month	2025/07/22 Fiscal Year 2025/03/2012 Month
Net Profit to Sales	98.88	-	112.21
Gross Profit to Sales	98.89	-	112.3
Operating Margin	98.73	-	98.15
Gross Profit to Sales	100	-	100
Net Profit to Gross Profit	98.88	-	112.21
Return on Assets (ROA)	46.91	-	28.89
Return on Capital (%)	379.99	-	181.8
Return on Equity (ROE)	62.92	-	49.36
Working Capital Return	76.21	-	67.97
Fixed Asset Return	106,052	-	59,642.13
Loan Benefit Assessment	1.34	-	1.71
Current Ratio	3.42	3.42	2.03
Quick Ratio	3.42	3.42	2.03
Liquidity Ratio	0	0	0
Net Working Capital	41,885,034	41,885,034	22,469,164
Current Assets Ratio	0.87	0.87	0.84
Receivables Collection Period	668.88	-	1,188.12
Inventory to Working Capital	0	0	0
Working Capital Turnover	0.77	-	0.61
Fixed Asset Turnover	1,072.48	-	531.51
Total Asset Turnover	0.47	-	0.26
Debt Ratio	0.25	0.25	0.41
Debt to Equity	0.34	0.34	0.71
Long-Term Debt to Equity	0	0	0
Current Debt to Equity	0.34	0.34	0.71
Equity Ratio	74.55	74.55	58.53
Debt Coverage Ratio	0.72	0.72	0.99

At a Glance